ECML
BBH icon

Eagle Capital Management (Louisiana)’s VanEck Biotech ETF BBH Stock Holding History

Eagle Capital Management (Louisiana)’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-30,816
Closed -$4.16M – 29
2015
Q2 		$4.16M Sell
30,816
-52
-0.2% -$6.91K 2.41% 11
2015
Q1 		$4M Sell
30,868
-1,309
-4% -$165K 2.12% 11
2014
Q4 		$3.71M Buy
32,177
+341
+1% +$38.4K 1.49% 12
2014
Q3 		$3.37M Sell
31,836
-730
-2% -$73.9K 1.29% 15
2014
Q2 		$3.11M Buy
32,566
+1,100
+3% +$98.6K 1.16% 22
2014
Q1 		$2.86M Buy
31,466
+12,576
+67% +$1.22M 1.12% 29
2013
Q4 		$1.67M Buy
+18,890
New +$1.58M 0.72% 32

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
VFAM
Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
LFM
Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return

Eagle Capital Management (Louisiana)'s BBH Position: Q3 2015 in Review

Eagle Capital Management (Louisiana) sold out of VanEck Biotech ETF (BBH) in Q3 2015, closing a stake of 30,816 shares — an estimated $4.16M sold.

Eagle Capital Management (Louisiana) first reported a position in BBH in Q4 2013 and held it in 7 quarters. The position peaked at $4.16M in Q2 2015. 83 funds tracked by Wall St. Rank hold BBH as of Q3 2015.

  • Eagle Capital Management (Louisiana) reported no remaining VanEck Biotech ETF position as of Q3 2015 after selling out during the quarter.
  • Eagle Capital Management (Louisiana) sold 30,816 VanEck Biotech ETF shares in Q3 2015, an estimated $4.16M.
  • Eagle Capital Management (Louisiana) first reported a position in VanEck Biotech ETF in Q4 2013 and held it in 7 quarters.
  • Eagle Capital Management (Louisiana)'s VanEck Biotech ETF position peaked at $4.16M in Q2 2015.
  • 83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2015.

Based on Eagle Capital Management (Louisiana)'s 13F filing for Q3 2015, filed 16 Nov 2015.